Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Oncology Injection Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Oncology Injection Drug market. Detailed analysis of key players, along with key growth strategies adopted by Oncology Injection Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Praecis Pharmaceuticals
Eli Lilly
AdvaCare
Ferring Pharmaceuticals
Genzyme
SG Biopharm
Merrimack
Pharmascience
Taj Oncology
Millennium Pharmaceuticals
Allos Therapeutics
Debiopharm
Celgene
CordenPharma
Alza
By Type:
Organs
Central Nervous System
Circulatory/Musculoskeletal System
By End-User:
Lymphoma
Myeloma
Prostate Cancer
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Injection Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Oncology Injection Drug Market Size and Growth Rate of Organs from 2016 to 2027
-
1.3.2 China Oncology Injection Drug Market Size and Growth Rate of Central Nervous System from 2016 to 2027
-
1.3.3 China Oncology Injection Drug Market Size and Growth Rate of Circulatory/Musculoskeletal System from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Oncology Injection Drug Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
1.4.2 China Oncology Injection Drug Market Size and Growth Rate of Myeloma from 2016 to 2027
-
1.4.3 China Oncology Injection Drug Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Oncology Injection Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Oncology Injection Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Organs
-
3.4.2 Market Size and Growth Rate of Central Nervous System
-
3.4.3 Market Size and Growth Rate of Circulatory/Musculoskeletal System
4 Segmentation of Oncology Injection Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Oncology Injection Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Oncology Injection Drug in Lymphoma
-
4.4.2 Market Size and Growth Rate of Oncology Injection Drug in Myeloma
-
4.4.3 Market Size and Growth Rate of Oncology Injection Drug in Prostate Cancer
5 Market Analysis by Regions
-
5.1 China Oncology Injection Drug Production Analysis by Regions
-
5.2 China Oncology Injection Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Oncology Injection Drug Landscape Analysis
-
6.1 North China Oncology Injection Drug Landscape Analysis by Major Types
-
6.2 North China Oncology Injection Drug Landscape Analysis by Major End-Users
7 Central China Oncology Injection Drug Landscape Analysis
-
7.1 Central China Oncology Injection Drug Landscape Analysis by Major Types
-
7.2 Central China Oncology Injection Drug Landscape Analysis by Major End-Users
8 South China Oncology Injection Drug Landscape Analysis
-
8.1 South China Oncology Injection Drug Landscape Analysis by Major Types
-
8.2 South China Oncology Injection Drug Landscape Analysis by Major End-Users
9 East China Oncology Injection Drug Landscape Analysis
-
9.1 East China Oncology Injection Drug Landscape Analysis by Major Types
-
9.2 East China Oncology Injection Drug Landscape Analysis by Major End-Users
10 Northeast China Oncology Injection Drug Landscape Analysis
-
10.1 Northeast China Oncology Injection Drug Landscape Analysis by Major Types
-
10.2 Northeast China Oncology Injection Drug Landscape Analysis by Major End-Users
11 Southwest China Oncology Injection Drug Landscape Analysis
-
11.1 Southwest China Oncology Injection Drug Landscape Analysis by Major Types
-
11.2 Southwest China Oncology Injection Drug Landscape Analysis by Major End-Users
12 Northwest China Oncology Injection Drug Landscape Analysis
-
12.1 Northwest China Oncology Injection Drug Landscape Analysis by Major Types
-
12.2 Northwest China Oncology Injection Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Praecis Pharmaceuticals
-
13.1.1 Praecis Pharmaceuticals Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Eli Lilly
-
13.2.1 Eli Lilly Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 AdvaCare
-
13.3.1 AdvaCare Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Ferring Pharmaceuticals
-
13.4.1 Ferring Pharmaceuticals Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Genzyme
-
13.5.1 Genzyme Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 SG Biopharm
-
13.6.1 SG Biopharm Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Merrimack
-
13.7.1 Merrimack Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Pharmascience
-
13.8.1 Pharmascience Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Taj Oncology
-
13.9.1 Taj Oncology Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Millennium Pharmaceuticals
-
13.10.1 Millennium Pharmaceuticals Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Allos Therapeutics
-
13.11.1 Allos Therapeutics Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Debiopharm
-
13.12.1 Debiopharm Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 Celgene
-
13.13.1 Celgene Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
-
13.14 CordenPharma
-
13.14.1 CordenPharma Company Profile and Recent Development
-
13.14.2 Market Performance
-
13.14.3 Product and Service Introduction
-
13.15 Alza
-
13.15.1 Alza Company Profile and Recent Development
-
13.15.2 Market Performance
-
13.15.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Oncology Injection Drug Market Size and Growth Rate of Organs from 2016 to 2027
-
Figure China Oncology Injection Drug Market Size and Growth Rate of Central Nervous System from 2016 to 2027
-
Figure China Oncology Injection Drug Market Size and Growth Rate of Circulatory/Musculoskeletal System from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Oncology Injection Drug Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
Figure China Oncology Injection Drug Market Size and Growth Rate of Myeloma from 2016 to 2027
-
Figure China Oncology Injection Drug Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Oncology Injection Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Oncology Injection Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Oncology Injection Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Oncology Injection Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Oncology Injection Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Organs
-
Figure Market Size and Growth Rate of Central Nervous System
-
Figure Market Size and Growth Rate of Circulatory/Musculoskeletal System
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Oncology Injection Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Oncology Injection Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Lymphoma
-
Figure Market Size and Growth Rate of Myeloma
-
Figure Market Size and Growth Rate of Prostate Cancer
-
Table China Oncology Injection Drug Production by Regions
-
Table China Oncology Injection Drug Production Share by Regions
-
Figure China Oncology Injection Drug Production Share by Regions in 2016
-
Figure China Oncology Injection Drug Production Share by Regions in 2021
-
Figure China Oncology Injection Drug Production Share by Regions in 2027
-
Table China Oncology Injection Drug Consumption by Regions
-
Table China Oncology Injection Drug Consumption Share by Regions
-
Figure China Oncology Injection Drug Consumption Share by Regions in 2016
-
Figure China Oncology Injection Drug Consumption Share by Regions in 2021
-
Figure China Oncology Injection Drug Consumption Share by Regions in 2027
-
Table North China Oncology Injection Drug Consumption by Types from 2016 to 2027
-
Table North China Oncology Injection Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Oncology Injection Drug Consumption Share by Types in 2016
-
Figure North China Oncology Injection Drug Consumption Share by Types in 2021
-
Figure North China Oncology Injection Drug Consumption Share by Types in 2027
-
Table North China Oncology Injection Drug Consumption by End-Users from 2016 to 2027
-
Table North China Oncology Injection Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Oncology Injection Drug Consumption Share by End-Users in 2016
-
Figure North China Oncology Injection Drug Consumption Share by End-Users in 2021
-
Figure North China Oncology Injection Drug Consumption Share by End-Users in 2027
-
Table Central China Oncology Injection Drug Consumption by Types from 2016 to 2027
-
Table Central China Oncology Injection Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Oncology Injection Drug Consumption Share by Types in 2016
-
Figure Central China Oncology Injection Drug Consumption Share by Types in 2021
-
Figure Central China Oncology Injection Drug Consumption Share by Types in 2027
-
Table Central China Oncology Injection Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Oncology Injection Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Oncology Injection Drug Consumption Share by End-Users in 2016
-
Figure Central China Oncology Injection Drug Consumption Share by End-Users in 2021
-
Figure Central China Oncology Injection Drug Consumption Share by End-Users in 2027
-
Table South China Oncology Injection Drug Consumption by Types from 2016 to 2027
-
Table South China Oncology Injection Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Oncology Injection Drug Consumption Share by Types in 2016
-
Figure South China Oncology Injection Drug Consumption Share by Types in 2021
-
Figure South China Oncology Injection Drug Consumption Share by Types in 2027
-
Table South China Oncology Injection Drug Consumption by End-Users from 2016 to 2027
-
Table South China Oncology Injection Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Oncology Injection Drug Consumption Share by End-Users in 2016
-
Figure South China Oncology Injection Drug Consumption Share by End-Users in 2021
-
Figure South China Oncology Injection Drug Consumption Share by End-Users in 2027
-
Table East China Oncology Injection Drug Consumption by Types from 2016 to 2027
-
Table East China Oncology Injection Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Oncology Injection Drug Consumption Share by Types in 2016
-
Figure East China Oncology Injection Drug Consumption Share by Types in 2021
-
Figure East China Oncology Injection Drug Consumption Share by Types in 2027
-
Table East China Oncology Injection Drug Consumption by End-Users from 2016 to 2027
-
Table East China Oncology Injection Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Oncology Injection Drug Consumption Share by End-Users in 2016
-
Figure East China Oncology Injection Drug Consumption Share by End-Users in 2021
-
Figure East China Oncology Injection Drug Consumption Share by End-Users in 2027
-
Table Northeast China Oncology Injection Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Oncology Injection Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Oncology Injection Drug Consumption Share by Types in 2016
-
Figure Northeast China Oncology Injection Drug Consumption Share by Types in 2021
-
Figure Northeast China Oncology Injection Drug Consumption Share by Types in 2027
-
Table Northeast China Oncology Injection Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Oncology Injection Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Oncology Injection Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Oncology Injection Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Oncology Injection Drug Consumption Share by End-Users in 2027
-
Table Southwest China Oncology Injection Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Oncology Injection Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Oncology Injection Drug Consumption Share by Types in 2016
-
Figure Southwest China Oncology Injection Drug Consumption Share by Types in 2021
-
Figure Southwest China Oncology Injection Drug Consumption Share by Types in 2027
-
Table Southwest China Oncology Injection Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Oncology Injection Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Oncology Injection Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Oncology Injection Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Oncology Injection Drug Consumption Share by End-Users in 2027
-
Table Northwest China Oncology Injection Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Oncology Injection Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Oncology Injection Drug Consumption Share by Types in 2016
-
Figure Northwest China Oncology Injection Drug Consumption Share by Types in 2021
-
Figure Northwest China Oncology Injection Drug Consumption Share by Types in 2027
-
Table Northwest China Oncology Injection Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Oncology Injection Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Oncology Injection Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Oncology Injection Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Oncology Injection Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Praecis Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Praecis Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Praecis Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Praecis Pharmaceuticals
-
Table Product and Service Introduction of Praecis Pharmaceuticals
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of AdvaCare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AdvaCare
-
Figure Sales and Growth Rate Analysis of AdvaCare
-
Figure Revenue and Market Share Analysis of AdvaCare
-
Table Product and Service Introduction of AdvaCare
-
Table Company Profile and Development Status of Ferring Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Ferring Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Ferring Pharmaceuticals
-
Table Product and Service Introduction of Ferring Pharmaceuticals
-
Table Company Profile and Development Status of Genzyme
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genzyme
-
Figure Sales and Growth Rate Analysis of Genzyme
-
Figure Revenue and Market Share Analysis of Genzyme
-
Table Product and Service Introduction of Genzyme
-
Table Company Profile and Development Status of SG Biopharm
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SG Biopharm
-
Figure Sales and Growth Rate Analysis of SG Biopharm
-
Figure Revenue and Market Share Analysis of SG Biopharm
-
Table Product and Service Introduction of SG Biopharm
-
Table Company Profile and Development Status of Merrimack
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merrimack
-
Figure Sales and Growth Rate Analysis of Merrimack
-
Figure Revenue and Market Share Analysis of Merrimack
-
Table Product and Service Introduction of Merrimack
-
Table Company Profile and Development Status of Pharmascience
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmascience
-
Figure Sales and Growth Rate Analysis of Pharmascience
-
Figure Revenue and Market Share Analysis of Pharmascience
-
Table Product and Service Introduction of Pharmascience
-
Table Company Profile and Development Status of Taj Oncology
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taj Oncology
-
Figure Sales and Growth Rate Analysis of Taj Oncology
-
Figure Revenue and Market Share Analysis of Taj Oncology
-
Table Product and Service Introduction of Taj Oncology
-
Table Company Profile and Development Status of Millennium Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Millennium Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Millennium Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Millennium Pharmaceuticals
-
Table Product and Service Introduction of Millennium Pharmaceuticals
-
Table Company Profile and Development Status of Allos Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allos Therapeutics
-
Figure Sales and Growth Rate Analysis of Allos Therapeutics
-
Figure Revenue and Market Share Analysis of Allos Therapeutics
-
Table Product and Service Introduction of Allos Therapeutics
-
Table Company Profile and Development Status of Debiopharm
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm
-
Figure Sales and Growth Rate Analysis of Debiopharm
-
Figure Revenue and Market Share Analysis of Debiopharm
-
Table Product and Service Introduction of Debiopharm
-
Table Company Profile and Development Status of Celgene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
-
Figure Sales and Growth Rate Analysis of Celgene
-
Figure Revenue and Market Share Analysis of Celgene
-
Table Product and Service Introduction of Celgene
-
Table Company Profile and Development Status of CordenPharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CordenPharma
-
Figure Sales and Growth Rate Analysis of CordenPharma
-
Figure Revenue and Market Share Analysis of CordenPharma
-
Table Product and Service Introduction of CordenPharma
-
Table Company Profile and Development Status of Alza
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alza
-
Figure Sales and Growth Rate Analysis of Alza
-
Figure Revenue and Market Share Analysis of Alza
-
Table Product and Service Introduction of Alza
-
